Vivic Corp
Change company Symbol lookup
Select an option...
VIVC Vivic Corp
BAC Bank of America Corp
DGRW WisdomTree U.S. Quality Dividend Growth Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DES WisdomTree U.S. SmallCap Dividend Fund
DEO Diageo PLC
DDF Delaware Investments Dividend and Income Fund
DAL Delta Air Lines Inc
D Dominion Energy Inc
Go

Company profile

Vivic Corp. is a start-up company. The Company operates as a travel agency that organizes individual and group tours in the Dominican Republic, such as cultural, recreational, sport, business, ecotours and other travel tours. The products and services provided by the Company will include custom packages according to the client’s specifications. The Company plan to develop and offer its own tours in the Dominican Republic as well as third-party suppliers. The Company has not generated any revenue.

Closing Price
$2.24
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
200
0

Global Allergy Immunotherapies Market 2020-2024, Featuring Key Vendor Profiles Including Aimmune Therapeutics, DBV Technologies and Merck KGaA - ResearchAndMarkets.com

5:36 am ET April 27, 2020 (BusinessWire) Print

The "Global Allergy Immunotherapies Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

This report on the global allergy immunotherapies market provides analysis on market size and forecasts trends, growth drivers, and challenges. The report includes a vendor analyis on key market players.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies. In addition, the growing popularity of slit is anticipated to boost the growth of the global allergy immunotherapies market.

The global allergy immunotherapies market is segmented as below:

Product:

SCIT SLIT

Geographic Segmentation:

APAC Europe MEA North America South America

Prominent vendors in global allergy immunotherapies market

The report provides a detailed analysis of key vendors operating in the global allergy immunotherapies market 2020-2024, including Aimmune Therapeutics Inc., ALK-Abell AS, Allergy Therapeutics Plc, ASIT Biotech SA, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., Laboratorios LETI SLU, Merck KGaA and Stallergenes Greer Plc .

Key Topics Covered:

Executive Summary

Market Overview

Market Landscape

Market ecosystem Value chain analysis

Market Sizing

Market definition Market segment analysis Market size 2019 Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

Market Segmentation by Product

Market segments Comparison by Product placement SCIT - Market size and forecast 2019-2024 SLIT - Market size and forecast 2019-2024 Market opportunity by Product

Customer landscape

Overview

Geographic Landscape

Geographic segmentation Geographic comparison Europe - Market size and forecast 2019-2024 North America - Market size and forecast 2019-2024 APAC - Market size and forecast 2019-2024 MEA - Market size and forecast 2019-2024 South America - Market size and forecast 2019-2024 Key leading countries Market opportunity by geography

Drivers, Challenges, and Trends

Market drivers Volume driver - Demand led growth Volume driver - Supply led growth Volume driver - External factors Volume driver - Demand shift in adjacent markets Price driver - Inflation Price driver - Shift from lower to higher-priced units Market challenges Market trends

Vendor Landscape

Overview Landscape disruption

Vendor Analysis

Vendors covered Market positioning of vendors Aimmune Therapeutics Inc. ALK-Abell AS Allergy Therapeutics Plc ASIT Biotech SA DBV Technologies SA HAL Allergy BV Jubilant Life Sciences Ltd. Laboratorios LETI SLU Merck KGaA Stallergenes Greer Plc

Appendix

Scope of the report Currency conversion rates for US$ Research methodology List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/ucr6qb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200427005299/en/

SOURCE: Research and Markets

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com 
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.